Stolnicu Simona, Tunde Csillip, Cadar Ana, Boros Monica
Department of Pathology, University of Medicine, Pharmacy, Sciences and Technology (UMFTS) of Târgu Mureş, Romania.
Department of Pathology, Faculty of Medicine and Pharmacy, University of Oradea, Romania.
Pol J Pathol. 2020;71(1):62-65. doi: 10.5114/pjp.2020.95417.
GATA-binding protein 3 (GATA3) is a sensitive and relatively specific marker in invasive breast carcinomas (IBC). The aim of the present study was to determine GATA3 expression among different histological and surrogate molecular breast carcinoma subtypes. Immunohistochemical staining of ER, PR, Ki67, HER2 and GATA3 was performed in a cohort of 84 consecutive cases of primary IBCs. The association of GATA3 expression with different histological subtypes, grades and surrogate intrinsic molecular subtypes was assessed. The overall positivity of GATA3 across various histological subtypes was 71.43% with no correlation with histological type (p = 0.849). Our study also confirmed that GATA3 exhibits a relatively high sensitivity for IBC (78.57%). GATA3 expression was positively correlated with low histological grades (G1/G2) vs. G3: p = 0.001) with most of G3 (57.89%) cases being negative and with luminal A (72.22%) and B (84.62%) subtypes (p = 0.00001) while most of the triple negative (87.5%) and HER2-overexpressed (66.67%) being negative. Caution must be payed however when dealing with an IBC metastasis of HER2-overexpressed or triple negative molecular subtypes or G3, since in these categories according to the present study, GATA3 is more frequently negative that previously reported and may be useless for diagnosis of tumor origin.
GATA结合蛋白3(GATA3)是浸润性乳腺癌(IBC)中一种敏感且相对特异的标志物。本研究的目的是确定不同组织学和替代分子乳腺癌亚型中的GATA3表达情况。对84例连续的原发性IBC病例进行了雌激素受体(ER)、孕激素受体(PR)、Ki67、人表皮生长因子受体2(HER2)和GATA3的免疫组织化学染色。评估了GATA3表达与不同组织学亚型、分级及替代内在分子亚型之间的关联。GATA3在各种组织学亚型中的总体阳性率为71.43%,与组织学类型无关(p = 0.849)。我们的研究还证实,GATA3对IBC具有相对较高的敏感性(78.57%)。GATA3表达与低组织学分级(G1/G2)呈正相关,与G3分级呈负相关(p = 0.001),大多数G3分级病例(57.89%)为阴性;与腔面A型(72.22%)和B型(84.62%)亚型呈正相关(p = 0.00001),而大多数三阴性(87.5%)和HER2过表达(66.67%)病例为阴性。然而,在处理HER2过表达或三阴性分子亚型或G3分级的IBC转移时必须谨慎,因为根据本研究,在这些类别中,GATA3阴性的频率比之前报道的更高,可能对肿瘤起源的诊断没有帮助。